Patient Data Reporting Featured Articles

11. What's In Store For EMRs After The Pandemic? 5/9/2022

    During the pandemic, our industry has realized that electronic medical record (EMR) systems needed some changes. This article discusses the new EMR specifics, including improved operability, advanced analytics, and smooth integration with diverse systems.

12. Best Practices For Designing Patient-Centric Decentralized Clinical Trials 4/12/2022

    Decentralized clinical trials are not universally applicable to all phases of a trial and therapeutic areas. The recommendations in this article may bring decentralized and hybrid trials to a more tangible and realistic view and, in essence, make them more executable.

13. 2021 Clinical Research Site Survey Findings: A Year In Flux 3/24/2022

    Since its inception in 2012, the Society for Clinical Research Sites (SCRS) has conducted an annual survey of clinical research site community members to derive insights, reveal trends, and ensure the site perspective is represented. This article summarizes the 2021 survey's findings.

14. Best Practices For EDMS Implementation For Virtual & Early-Stage Pharmaceuticals 12/14/2021

    Since the beginning of the pandemic, the clinical trials industry has rapidly adopted electronic documentation management systems (EDMS). However, for virtual and early-stage pharmaceuticals, an EDMS can pose several challenges. This article highlights the key factors that you should consider when evaluating the adoption of an EDMS to avoid the most common pitfalls.

15. Data Interoperability: The First Step To Leverage ML & AI In Clinical Trials 12/9/2021

    The first hurdle we need to overcome to leverage machine learning and AI in clinical development is data interoperability. We must break data silos, find a way to make the data points communicate with one another within the drug development continuum, and analyze each data point in its full context. This article also delves into the importance of metadata and the differences between different data formats.

16. The State of Real-World Data – And Where We Go From Here 12/7/2021

    There are many questions that a lot of clinical executives have about real-world data (RWD) and real-world evidence. There are questions about the quality and completeness of the data, the new digital apps generating data, patient privacy, its use in synthetic control arms, and the impact it might have on the patient diversity problem.

17. Digitally Enabled Clinical Trials: A Practical Guide 12/2/2021

    Undoubtedly, digital trials will stay as the world coexists with the pandemic, so it is essential for both sponsors and sites to be early adopters. This article will examine the benefits and challenges of digital clinical trials and identify key considerations for sponsors and sites as the world continues to navigate the new normal.

18. Our Lessons Learned In Implementing AI In Clinical Development 11/16/2021

    Taiho Oncology had multiple sources of clinical data that weren't being leveraged to their fullest potential. When they implemented an AI-powered data analytics platform, they obtained a single source of truth for data analysis and reporting, and they learned a number of valuable process- and people-oriented lessons along the way.

19. Clinical Trials: Envisioning A Future Where Technology Expedites Your Investigational Product's Labeling & Shipment 10/14/2021

    When you assess other industries and companies like Amazon, Tesla, and Coca Cola, each has a commanding use of innovation and technology to ensure they have what they need, when they need it, and that how it gets from pick-to-pack is swift and error-free. Some clinical trials operatives may say, “but they are not required to follow the GMPs” or “we work in a highly regulated industry.” To those, I say: that's an excuse. 

20. Co-Creating With Patients: The New Guide To Expanded Access 10/12/2021

    Recently, Janssen Pharmaceutical Companies had the privilege of working with patients and advocacy groups to co-create a resource about expanded access for patients and caregivers. This article shares that story and describes how patients will benefit from the resource.